Literature DB >> 8178770

Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors.

M F Bugg1, R C Ribeiro, P K Roberson, R V Lloyd, R Sandrini, J B Silva, S Epelman, D N Shapiro, D M Parham.   

Abstract

Although the relationship between pathologic features and clinical outcome is well established in adult adrenocortical neoplasms, the prognostic value of these features in pediatric adrenocortical neoplasms (PACN) is unclear. In a series of PACNs from 54 Brazilian children, the authors retrospectively investigated the prognostic value of histologic classification, ploidy, proliferative index, and size (as tumor weight or greater diameter). Histologic classification was most predictive of clinical behavior: there were no failures in 11 adenomas, 5 failures in 27 low-grade carcinomas, and 9 failures in 16 high-grade carcinomas (P = .0003). Tumor weight was predictive of failure in tumors weighing > or = 100 versus < 100 g (P = .04), and a trend was found toward failure among tumors measuring > or = 5 cm, as opposed to those < 5 cm (P = .07). Proliferative index was marginally related to failure (P = .05 at < 11% vs. > or = 11% and .07 at < 10% vs. > or = 10%), and ploidy was not significantly predictive of outcome (P = .25). Histologic type and tumor weight were the most reliable predictors of outcome in PACN.

Entities:  

Mesh:

Year:  1994        PMID: 8178770     DOI: 10.1093/ajcp/101.5.625

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Discerning malignancy in resected adrenocortical neoplasms.

Authors:  H Sasano; T Suzuki; T Moriya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.

Authors:  Gaurav Chatterjee; Shatavisha DasGupta; Gautam Mukherjee; Moumita Sengupta; Paromita Roy; Indu Arun; Chhanda Datta; Prafulla Kumar Mishra; Sugato Banerjee; Uttara Chatterjee
Journal:  Pediatr Surg Int       Date:  2015-04-17       Impact factor: 1.827

3.  Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study.

Authors:  Emilia Modolo Pinto; Carlos Rodriguez-Galindo; John Kim Choi; Stanley Pounds; Zhifa Liu; Geoffrey Neale; David Finkelstein; John M Hicks; Alberto S Pappo; Bonald C Figueiredo; Raul C Ribeiro; Gerard P Zambetti
Journal:  Clin Cancer Res       Date:  2016-06-15       Impact factor: 12.531

4.  Androgen secreting adrenocortical tumours.

Authors:  O D Wolthers; F J Cameron; I Scheimberg; J W Honour; P C Hindmarsh; M O Savage; R G Stanhope; C G Brook
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

5.  Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?

Authors:  Kelsey A Flynt; Jonathan R Dillman; Matthew S Davenport; Ethan A Smith; Tobias Else; Peter J Strouse; Elaine M Caoili
Journal:  Pediatr Radiol       Date:  2015-03-21

6.  Adrenocortical tumors in childhood.

Authors:  K L Narasimhan; R Samujh; A Bhansali; R K Marwaha; S K Chowdhary; B D Radotra; K L N Rao
Journal:  Pediatr Surg Int       Date:  2003-07-19       Impact factor: 1.827

7.  TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence.

Authors:  Ana L Seidinger; Isabel P Caminha; Maria J Mastellaro; Carmen S Gabetta; Alexandre E Nowill; Vitória R P Pinheiro; José A Yunes
Journal:  Mol Genet Genomic Med       Date:  2020-06-27       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.